Skip to main content

Alprazolam

FDA recalls

6 rows

DateCompany and reasonClass
Apr 27, 2022Viatris Inc
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.		Class II · Terminated
Sep 23, 2015Pfizer Inc.
Subpotent Drug		Class II · Terminated
Dec 16, 2014Neolpharma, Inc.
Subpotent Drug		Class II · Terminated
Jul 24, 2014Sandoz Incorporated
Presence of Foreign Substance; tablets may contain stainless steel metal particulates		Class II · Terminated
Feb 9, 2014Actavis Elizabeth LLC
Failed Tablet/Capsule Specifications: Complaints were received for significant tablet erosion for Alprazolam 1 mg.		Class II · Terminated
Oct 8, 2013Actavis Elizabeth LLC
Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets		Class II · Terminated

← Back to Alprazolam

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).